Brought to you by:
BEST-CLI: Trial results endure in analysis of patients who presented with diabetes
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of wounds and infections, according to a recently presented retrospective analysis of BEST-CLI randomized controlled trial data.…
Rates of MAE and reintervention following F/BEVAR remain ‘stable,’ Aortic Research Consortium data show
Latest study out of consortium details trends and outcomes after F/BEVAR procedures carried out over an eight-year period under consortium of 10 physician-sponsored IDEs. Despite increasing repair extent and complexity, rates of technical failure, adverse events and reintervention remained “stable”…
Humacyte clinical results published in JAMA Surgery
Humacyte today announced the publication of clinical results evaluating the efficacy and safety of the acellular tissue engineered vessel (ATEV) in the repair of extremity civilian and military injuries in JAMA Surgery, an American Medical Association peer-reviewed journal. The publication…
One-year data from VenoValve US pivotal trial emerges
Envveno Medical has announced that it will present one-year data on all patients from the VenoValve US pivotal trial today at the VEITHsymposium (19–23 November, New York, USA). The definitive one-year data support the application submitted earlier this week by Envveno Medical seeking…
PMA application submitted for VenoValve device
enVVeno Medical today announced it has submitted an application with the U.S. Food and Drug Administration (FDA) seeking approval to market the VenoValve—a surgical venous valve implant for chronic venous insufficiency—in the USA. Definitive one year data from the application…
Research suggests arm vein is the best alternative bypass conduit to GSV in patients with CLTI
A new analysis has found arm vein to be the most suitable alternative conduit to great saphenous vein (GSV) in chronic limb-threatening ischemia (CLTI) patients, particularly in below-knee bypass targets. Prosthetic grafts also represent an adequate option, the researchers add,…
Jimenez joins JVS-CIT as DEI editor
The Journal of Vascular Surgery-Cases, Innovations and Techniques (JVS-CIT) has appointed Juan Carlos Jimenez, MD, as its new associate editor and diversity, equity and inclusion (DEI) officer. Jimenez, who serves as clinical professor of surgery and director of the Gonda…
SVN hosts virtual roundtable on PAD awareness
On Tuesday, Sept. 24, The Society for Vascular Nursing (SVN), in collaboration with the PAD Collaborative and the American Association of Wound Care (AAWC), presented a virtual roundtable titled “PAD: What is it? Leg Circulation Disease is More Common Than…
Class of 2024–25: VQI announces third annual set of Fellowship in Training Program awardees
The Vascular Quality Initiative (VQI) Patient Safety Organization’s Fellowship in Training (FIT) Program has announced its third class of FIT participants for 2024–25 alongside the new FIT scholars. VQI FIT began in January 2022 and is designed to introduce residents…
Vascular Research Initiatives Conference abstracts due
Abstracts for the 2025 Vascular Research Initiatives Conference (VRIC) are being accepted through Nov. 20. VRIC, which is held in Baltimore, Maryland, this year, emphasizes the exchange of basic and translational vascular science that stimulates thoughtful discussion and motivates participants…